The Twilight Zone of Hong Kong Equities: Delistings, Pivots, and Frozen TickersGlobal Report·Aug 11 at 04:43 AM01858-6.84%02570-0.35%
Beijing Chunlizhengda reshapes board leadership and committees for sixth sessionTip Ranks·Jun 26 at 08:16 AM01858-6.84%
Beijing Chunlizhengda Confirms Valid Poll Results at Extraordinary General MeetingTip Ranks·Jun 25 at 05:42 PM01858-6.84%
Beijing Chunlizhengda Names Veteran R&D Executive as Employee DirectorTip Ranks·Jun 25 at 05:42 PM01858-6.84%
Beijing Chunlizhengda Deploys Idle Funds Into RMB895 Million Bank Wealth ProductsTip Ranks·Jun 25 at 10:08 AM01858-6.84%
Chunlizhengda Confirms Valid 2025 AGM and A-Shareholder Meeting VotesTip Ranks·May 26 at 05:50 PM688236-2.92%01858-6.84%
Beijing Chunlizhengda Sets Final Dividend and Clarifies H-Share Tax TreatmentTip Ranks·May 26 at 05:49 PM688236-2.92%01858-6.84%
Beijing Chunlizhengda Sets Final 2025 Dividend, Clarifies Withholding Tax RulesTip Ranks·Apr 30 at 03:44 AM01858-6.84%688236-2.92%
Over Half of Listed Chinese Drugmakers See 2025 Profit Grow Buoyed by Innovative Medicines, Overseas BusinessYicai·Apr 8 at 01:47 AM01276-3.92%688428-2.58%
"Performance" Chunli Medical's annual net profit is 273 million RMB, an increase of 118%, with earnings per share of 0.15 RMBAASTOCKS·Mar 30 at 09:31 PM01858-6.84%688236-2.92%
"Performance" Chunli Medical's annual net profit is 272 million RMB, an increase of 117.7%AASTOCKS·Mar 1 at 04:15 AM688236-2.92%01858-6.84%
"Profit Alert" Chunli Medical forecasts annual net profit to increase by at least 96% to 245 million RMBAASTOCKS·Jan 29 at 08:53 AM688236-2.92%01858-6.84%
